Corporate calendar for Century Therapeutics, Inc. (IPSC): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-11 | ||
| 2026-09-11 | $-39.98 | |
| 2026-09-11 | $-0.02 | $22M |
| 2026-09-11 | $0.44 | $14M |
| 2026-09-11 | ||
| 2026-09-11 |
Price
| Price | $1.86 |
| Market Cap | $161M |
| Exchange | NASDAQ |
| Country | US |
Related companies: COEP · CUE · EQ · GNTA · KPTI · MDCX · OSTX
Explore sector: Healthcare · Biotechnology
More sections of IPSC: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks